Selpercatinib (LOXO-292) in patients (pts) with RET-altered thyroid cancer
Publication/Presentation Date
7-2021
Volume
32
Issue
4
First Page
289
Last Page
289
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Hematology-Medical Oncology Division
Document Type
Article
COinS